Related Experiment Video

Updated: Jul 10, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with

Matthias Preusser1, Melitta Kitzwoegerer, Herbert Budka

  • 1Institute of Neurology, Medical University of Vienna, Vienna, Austria. matthias.preusser@meduniwien.ac.at

Neuropathology : Official Journal of the Japanese Society of Neuropathology
|November 21, 2007
PubMed

Insights

This study details a patient with hypoparathyroidism who developed dementia and parkinsonism, exhibiting brain calcification and multiple system atrophy (MSA) neuropathology. Further research is needed to correlate alpha-synucleinopathy with Fahr's syndrome.

Area of Science:

  • Neurology
  • Pathology
  • Genetics

Background:

  • Idiopathic brain calcification has been linked to neurological disorders.
  • Multiple System Atrophy (MSA) is a neurodegenerative disease characterized by alpha-synucleinopathy.

Observation:

  • A female patient with a history of hypoparathyroidism since age 9 developed dementia and parkinsonism in her 50s.
  • Neuropathology revealed severe Fahr-type brain calcifications and prominent MSA-type alpha-synucleinopathy.
  • The patient had a healthy identical twin and no family history of neurological disease.

Findings:

  • The case presents a unique co-occurrence of Fahr's syndrome and multiple system atrophy (MSA).
  • Alpha-synucleinopathy was observed in conjunction with bilateral striopallidodentate calcification.

Implications:

  • This case highlights a potential link between hypoparathyroidism, Fahr's syndrome, and alpha-synucleinopathy.
  • Further investigation into alpha-synuclein accumulation in Fahr's syndrome is warranted to establish a definitive correlation.
  • Understanding this association may offer new insights into neurodegenerative disease mechanisms.

More Related Videos

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...